Weight & metabolic
Semaglutide
Also written: GLP-1 receptor agonist
The most-searched compound in this whole catalogue, an approved drug and a supply-channel lookalike at the same time. Getting that distinction right is the entire point of this page.
Semaglutide is a peptide in the class known as GLP-1 receptor agonists. It is also the name on some of the most recognised approved drug products in the world, which is exactly why it needs the most careful page in this library: the same word covers a branded, approved medicine and material moving through supply channels, and those are not the same thing.
Branded, approved — and compounded lookalikes
There are approved semaglutide drug products, approved for specific indications, made to a specific standard. There is also compounded and supply-channel semaglutide that shares the name and does not automatically share the approval, the formulation, or the indication. This is the distinction that matters more here than anywhere else in the catalogue, because the branded products are so well known that the name alone carries an authority the supply-channel material has not earned.
What the format changes
It is supplied both as a lyophilized vial for reconstitution and as pre-filled or refillable injection pens. The pen is not merely a convenience — it changes who does the measuring, what can go wrong, and how the product must be stored and handled. "Vial or pen" is a real operational decision, not a preference.
The class is genuinely debated
It would be dishonest to present this class as settled. There is real and serious discussion among clinicians about the GLP-1 drugs — what they do well, what the trade-offs are, and who they suit. For one careful, credentialed view of GLP-1s and their effects, a rheumatologist works through the evidence in a talk on our worth-watching shelf. We link the debate rather than pretend it away.
What to ask before ordering
The standard four, and the sharp ones this compound demands: is this the approved drug product or a compound sharing its name, what does the label state as intended use, and — for a pen — how is it filled, stored, and what documentation accompanies the device as well as the drug.
What we are not claiming
Anything about weight, metabolism, or any outcome, and no dose. Nothing we supply is approved for the prevention, treatment, mitigation or cure of any disease. Whether a GLP-1 is appropriate for a person is a decision for a clinician who can see the whole picture, and it is a decision this class's debate makes more, not less, individual.
Questions we get about Semaglutide
- Is semaglutide FDA approved?
- There are approved semaglutide drug products for specific indications. That does not mean a compounded or supply-channel vial or pen sharing the name carries that approval, formulation or indication — the shared name is not shared approval.
- What is the difference between the vial and the pen?
- The pen changes who measures the dose, what can go wrong, and how it must be stored. It is an operational decision, and the device carries its own documentation questions on top of the drug.
- Is the GLP-1 class settled science?
- No. There is serious, ongoing clinical debate about the GLP-1 drugs. We link a credentialed discussion of it rather than present the class as decided.
Read next from the library
- What a peptide actually isNot a drug class, not a supplement, not a hormone. A length. Once that lands, most of the confusion in this category goes away.
- "Is it FDA approved?" is usually the wrong questionNot because the answer is uncomfortable, but because approval, registration, clearance and certification are four different things — and only one of them is usually on offer.
- How to read a certificate of analysisThe document that separates a supply chain you can defend from one you are trusting. Six fields, and one question that matters more than the rest.